A High-Throughput Screen for Inhibitors of the Hsp90-Chaperone Machine
Methods in molecular biology, January 2018
Jason Davenport, Lakshmi Galam, Robert L. Matts
Hsp90 has emerged as a key chemotherapeutic target for the development of drugs for the treatment of cancer and neurodegenerative diseases. The shortcomings of many of the Hsp90 inhibitors that have made it to clinical trials have bolstered the need to identify new lead compounds with superior properties. Here, we describe a high-throughput screen for the identification of Hsp90 inhibitors based on the refolding of thermally denatured firefly luciferase.
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.